TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29139007

Group type: COMPARATOR
Intervention: RT-HIIT
Number of subjects: 240

Group type: COMPARATOR
Intervention: AT-HIIT
Number of subjects: 240
Study: 27178009

Group type: EXPERIMENTAL
Intervention: Low learning stimulation in the home at age 3
Number of subjects: 587

Group type: EXPERIMENTAL
Intervention: Language delays in first grade
Number of subjects: 587

Group type: EXPERIMENTAL
Intervention: Home learning environment at age 3
Number of subjects: 587
Study: 24458078

Group type: EXPERIMENTAL
Intervention: Ferumoxytol (1.02 g, 2 × 510‐mg injections)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Iron sucrose (1.0 g, administered as slow injection or infusion)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Ferumoxytol
Number of subjects: 162

Group type: COMPARATOR
Intervention: Iron sucrose
Number of subjects: 162
Study: 22672407

Group type: EXPERIMENTAL
Intervention: Personalised care intervention involving a comprehensive assessment and regular telephone reviews over a 6-month period.
Number of subjects: 81

Group type: COMPARATOR
Intervention: Usual general practitioner (GP) care
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Personalised care intervention
Number of subjects: 81
Study: 20173678

Group type: EXPERIMENTAL
Intervention: Prone position (group 1)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Knee-chest position (group 2)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Both positions (prone and knee-chest)
Number of subjects: 45
Study: 17824865

Group type: EXPERIMENTAL
Intervention: Short waiting time group (WT < or = 3 months)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Non-fixed waiting time group
Number of subjects: 310
Study: 16897907

Group type: EXPERIMENTAL
Intervention: Rhythmic auditory stimulation with metronomic beats imbedded in music
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Rhythmic auditory stimulation with metronomic beats without music
Number of subjects: 28

Group type: COMPARATOR
Intervention: No auditory stimulus
Number of subjects: 28
Study: 12072848

Group type: EXPERIMENTAL
Intervention: All 3 palpation procedures
Number of subjects: 29
Study: 10325782

Group type: EXPERIMENTAL
Intervention: Terbutaline infusion
Number of subjects: 25

Group type: COMPARATOR
Intervention: Saline infusion (Control)
Number of subjects: 25
Study: 8961312

Group type: EXPERIMENTAL
Intervention: Modified Control Question Test with unambiguous questions
Number of subjects: 0
Study: 2019314

Group type: EXPERIMENTAL
Intervention: 2 or 3 mg/kg diazoxide given 2.5 min before laryngoscopy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 30
Study: 6765414

Group type: EXPERIMENTAL
Intervention: Standard amikacin dosing (15 mg/kg per day in four divided doses) with ticarcillin or piperacillin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacokinetically adjusted amikacin dosing (mean dosage of 29.4 mg/kg per day) with ticarcillin or moxalactam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (previous amikacin-plus-ticarcillin trial with 15 mg/kg per day)
Number of subjects: 0
Study: 29759944

Group type: EXPERIMENTAL
Intervention: Active tDCS (cathode-F3/anode-F4 montage) at 2 mA for 20 min
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 28
Study: 28094468

Group type: EXPERIMENTAL
Intervention: inside‐out transobturator tension‐free vaginal tape (TO‐TVT)
Number of subjects: 341

Group type: COMPARATOR
Intervention: outside‐in transobturator tape (TOT‐ARIS)
Number of subjects: 341
Study: 25985046

Group type: EXPERIMENTAL
Intervention: Continuation-phase cognitive therapy (CT) for 8 months
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Double-blinded fluoxetine for 8 months
Number of subjects: 241

Group type: COMPARATOR
Intervention: Pill placebo for 8 months
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Continuation-phase treatments (CT, fluoxetine, placebo)
Number of subjects: 241
Study: 24001030

Group type: EXPERIMENTAL
Intervention: ECA (Embodied Conversational Agent)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Control (pedometer only)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: ECA (Embodied Conversational Agent) for participants with adequate health literacy
Number of subjects: 263

Group type: COMPARATOR
Intervention: Control (pedometer only) for participants with adequate health literacy
Number of subjects: 263
Study: 21156438

Group type: EXPERIMENTAL
Intervention: True cooling
Number of subjects: 6

Group type: COMPARATOR
Intervention: Sham cooling
Number of subjects: 6

Group type: COMPARATOR
Intervention: No cooling
Number of subjects: 6
Study: 19061808

Group type: EXPERIMENTAL
Intervention: Mini-implants for en-masse retraction (G1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional methods of anchorage preservation (G2)
Number of subjects: 30
Study: 17718288

Group type: EXPERIMENTAL
Intervention: Cinnamon cassia powder 1.5 g/d
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 12723628

Group type: EXPERIMENTAL
Intervention: P54FP
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 11296163

Group type: COMPARATOR
Intervention: pMDI alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: pMDI with small-volume plastic spacer
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: pMDI with cardboard tube
Number of subjects: 12
Study: 9283507

Group type: EXPERIMENTAL
Intervention: Cognitive therapy added to group drug counseling
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Supportive-expressive psychodynamic therapy added to group drug counseling
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Individual drug counseling added to group drug counseling
Number of subjects: 480

Group type: COMPARATOR
Intervention: Group drug counseling alone
Number of subjects: 480
Study: 8393895

Group type: EXPERIMENTAL
Intervention: 30 mg oral d-fenfluramine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2942295

Group type: EXPERIMENTAL
Intervention: Weichang Fuyuan Decoction
Number of subjects: 406
Study: 29018051

Group type: EXPERIMENTAL
Intervention: RFA + LTLD
Number of subjects: 701

Group type: COMPARATOR
Intervention: RFA
Number of subjects: 701
Study: 27044486

Group type: EXPERIMENTAL
Intervention: History model (based on Asthma Control Questionnaire score, current smoking, chronic sinusitis, previous hospital admission for asthma, and ≥1 severe exacerbation in the previous year)
Number of subjects: 611

Group type: EXPERIMENTAL
Intervention: History + spirometry model
Number of subjects: 611

Group type: EXPERIMENTAL
Intervention: History + spirometry + FeNO model
Number of subjects: 611

Group type: COMPARATOR
Intervention: External validation of the three models
Number of subjects: 611
Study: 24322805

Group type: EXPERIMENTAL
Intervention: Intrastromal MyoRing implantation at 250 μm depth
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intrastromal MyoRing implantation at 300 μm depth
Number of subjects: 0
Study: 23946472

Group type: EXPERIMENTAL
Intervention: PSA screening era (post-PSA screening)
Number of subjects: 1207

Group type: COMPARATOR
Intervention: Pre-PSA screening era
Number of subjects: 1207
Study: 21424149

Group type: EXPERIMENTAL
Intervention: Vertical incision (group 1)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Parallel incision (group 2)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 52
Study: 18325461

Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg/day)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control (no statins)
Number of subjects: 110
Study: 16614008

Group type: EXPERIMENTAL
Intervention: Home-based exercise programme (n = 9)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (n = 11)
Number of subjects: 20
Study: 14636813

Group type: EXPERIMENTAL
Intervention: Intervention (school-based obesity prevention program)
Number of subjects: 1368

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 1368

Group type: EXPERIMENTAL
Intervention: BIA (Bioelectric Impedance Analysis)
Number of subjects: 1368

Group type: EXPERIMENTAL
Intervention: Skinfolds and combination of methods
Number of subjects: 1368
Study: 11776204

Group type: EXPERIMENTAL
Intervention: LHRH‐a (150 micrograms/d, i.m.) plus norethindrone (2.5 mg/d, p.o.)
Number of subjects: 77

Group type: COMPARATOR
Intervention: LHRH‐a (150 micrograms/d, i.m.)
Number of subjects: 77
Study: 8634919

Group type: EXPERIMENTAL
Intervention: Oral hydralazine (75 mg qid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not receiving hydralazine)
Number of subjects: 0
Study: 1631944

Group type: EXPERIMENTAL
Intervention: MALG (20 mg/kg/day)
Number of subjects: 173

Group type: COMPARATOR
Intervention: OKT3 (5 mg/day)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: MALG and OKT3
Number of subjects: 173
Study: 3159468

Group type: EXPERIMENTAL
Intervention: alpha-methyldopa
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: propranolol
Number of subjects: 20
Study: 29446654

Group type: EXPERIMENTAL
Intervention: Yoghurt containing Lactobacillus gasseri PA-3
Number of subjects: 25

Group type: COMPARATOR
Intervention: Yoghurt without Lactobacillus gasseri PA-3 (Control)
Number of subjects: 25
Study: 29048942

Group type: EXPERIMENTAL
Intervention: Watson MDI program
Number of subjects: 41
Study: 27266196

Group type: EXPERIMENTAL
Intervention: Kou Yan Qing Ke Li
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (0.9% sodium chloride, lidocaine, dexamethasone, vitamin B2 gargle)
Number of subjects: 60
Study: 24849445

Group type: EXPERIMENTAL
Intervention: 20% mannitol (2 ml/kg, infused for over 20 min)
Number of subjects: 33

Group type: COMPARATOR
Intervention: 15% hypertonic saline (0.42 ml/kg, administered as a bolus via a central venous catheter)
Number of subjects: 33
Study: 22794787

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Psycho-education (control group)
Number of subjects: 16
Study: 20395226

Group type: EXPERIMENTAL
Intervention: Atorvastatin + N-acetylcysteine (NAC)
Number of subjects: 130

Group type: COMPARATOR
Intervention: N-acetylcysteine (NAC) alone
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Atorvastatin + NAC
Number of subjects: 130
Study: 18628697

Group type: EXPERIMENTAL
Intervention: VDR FF genotype
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Family history of myocardial infarction
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: High body mass index at age 40
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Long working hours
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Working with night shift
Number of subjects: 189
Study: 16649884

Group type: EXPERIMENTAL
Intervention: Personalized feedback intervention mailed to participants
Number of subjects: 177

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 177
Study: 12794414

Group type: EXPERIMENTAL
Intervention: Dexamethasone, 1 mg/kg iv (group II, n = 15)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (group I, n = 13)
Number of subjects: 28
Study: 11035613

Group type: EXPERIMENTAL
Intervention: Double therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triple therapy
Number of subjects: 0
Study: 8776911

Group type: EXPERIMENTAL
Intervention: Self-directed educational intervention focusing on detection of psychological distress
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 1624000

Group type: EXPERIMENTAL
Intervention: Transuterotubal insemination
Number of subjects: 160

Group type: COMPARATOR
Intervention: Intrauterine insemination (IUI)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Overall (both methods)
Number of subjects: 160
Study: 6482651

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 31680111

Group type: EXPERIMENTAL
Intervention: Text/email appointment reminders and education messages
Number of subjects: 257

Group type: COMPARATOR
Intervention: Standard-of-care
Number of subjects: 257
Study: 28605472

Group type: EXPERIMENTAL
Intervention: ACT + primaquine (0.25 mg/kg)
Number of subjects: 274

Group type: COMPARATOR
Intervention: ACT alone
Number of subjects: 274
Study: 26608219

Group type: EXPERIMENTAL
Intervention: ActiGraph
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: activPAL
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: OSPAQ
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: WSQ
Number of subjects: 42
Study: 24095885

Group type: EXPERIMENTAL
Intervention: Desflurane/fentanyl
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sevoflurane/fentanyl
Number of subjects: 80
Study: 21471799

Group type: EXPERIMENTAL
Intervention: Sennoside A+B calcium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sodium phosphate
Number of subjects: 0
Study: 18641191

Group type: COMPARATOR
Intervention: 800 microg/d of folic acid for 3 years
Number of subjects: 294

Group type: COMPARATOR
Intervention: 0, 50, 100, 200, 400, 600, or 800 microg/d of folic acid for 12 weeks
Number of subjects: 294
Study: 17238779

Group type: EXPERIMENTAL
Intervention: Decision support reminders and computer generated provider feedback
Number of subjects: 0
Study: 12676345

Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10912897

Group type: EXPERIMENTAL
Intervention: salbutamol (4 mg)
Number of subjects: 16
Study: 8729666

Group type: EXPERIMENTAL
Intervention: Allergic asthmatics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy individuals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Allergic individuals
Number of subjects: 0
Study: 1330880

Group type: EXPERIMENTAL
Intervention: Azithromycin 1000 mg single dose
Number of subjects: 130

Group type: COMPARATOR
Intervention: Doxycycline 100 mg twice daily for 7 days
Number of subjects: 130
Study: 6695766

Group type: EXPERIMENTAL
Intervention: Prazosin added to propranolol (reduced to 120 mg/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Prazosin added after tapering and discontinuing propranolol
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 14
Study: 30106494

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone
Number of subjects: 570

Group type: COMPARATOR
Intervention: Buprenorphine
Number of subjects: 570
Study: 26851987

Group type: EXPERIMENTAL
Intervention: MEMS caps
Number of subjects: 153

Group type: COMPARATOR
Intervention: MMAS self-report adherence ratings
Number of subjects: 153
Study: 25602629

Group type: EXPERIMENTAL
Intervention: COMBO condition (PBIS + SEL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PBIS alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SEL alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: BAU (business-as-usual)
Number of subjects: 0
Study: 23090620

Group type: EXPERIMENTAL
Intervention: Capecitabine tablet formulation (500 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control formulation of capecitabine (500 mg)
Number of subjects: 0
Study: 20602506

Group type: EXPERIMENTAL
Intervention: Laparoscopic approach
Number of subjects: 268

Group type: COMPARATOR
Intervention: Open approach
Number of subjects: 268
Study: 19120715

Group type: EXPERIMENTAL
Intervention: Valsartan 320 mg/d
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ) 25 mg/d
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Valsartan/HCTZ 320/25 mg/d
Number of subjects: 566
Study: 16357487

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) treatment, n=62
Number of subjects: 88

Group type: COMPARATOR
Intervention: Baseline food intake before GH treatment
Number of subjects: 88

Group type: COMPARATOR
Intervention: Baseline serum levels
Number of subjects: 88
Study: 12448161

Group type: EXPERIMENTAL
Intervention: Physical training intervention group
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (not activated)
Number of subjects: 46
Study: 10607968

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 8745024

Group type: EXPERIMENTAL
Intervention: Eyepatches
Number of subjects: 203

Group type: COMPARATOR
Intervention: Headbox (control)
Number of subjects: 203
Study: 16296712

Group type: EXPERIMENTAL
Intervention: Amlodipine (5‐10 mg once daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diltiazem (30‐60 mg three times daily)
Number of subjects: 40
Study: 7211775

Group type: EXPERIMENTAL
Intervention: Terbutaline 3 microgram/kg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Terbutaline 6 microgram/kg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Terbutaline 12 microgram/kg
Number of subjects: 26

Group type: COMPARATOR
Intervention: Epinephrine 10 microgram/kg
Number of subjects: 26
Study: 30503386

Group type: EXPERIMENTAL
Intervention: 250 mg of testosterone cypionate
Number of subjects: 12
Study: 27669442

Group type: EXPERIMENTAL
Intervention: Heavier-load resistance training (3 sets of 8-12 repetitions; n = 16)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Lighter-load resistance training (3 sets of 20-25 repetitions; n = 16)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (maintained regular activity habits; n = 14)
Number of subjects: 32
Study: 27374668

Group type: EXPERIMENTAL
Intervention: Repaglinide (0.25 or 0.5 mg just before breakfast and dinner twice daily)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Repaglinide (0.25 or 0.5 mg just before meals thrice daily)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Sulfonylurea (continuing treatment)
Number of subjects: 78
Study: 23483320

Group type: EXPERIMENTAL
Intervention: parecoxib sodium (40 mg) intravenously (IV) at the completion of surgery and once every 12 h for a total of 6 times postoperatively
Number of subjects: 100

Group type: COMPARATOR
Intervention: placebo (normal saline 2 mL IV at the same time points)
Number of subjects: 100
Study: 21724350

Group type: EXPERIMENTAL
Intervention: sorafenib
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: sunitinib
Number of subjects: 42

Group type: COMPARATOR
Intervention: sorafenib and sunitinib
Number of subjects: 42
Study: 19463203

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate nasal spray (FFNS), 110 microg
Number of subjects: 536

Group type: COMPARATOR
Intervention: Fexofenadine, 180 mg
Number of subjects: 536

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 536
Study: 17223551

Group type: EXPERIMENTAL
Intervention: Serum 25(OH)D levels in the second tertile (range 5.5‐66.1 ng/ml)
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Serum 25(OH)D levels in the third tertile
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Serum 25(OH)D levels above the median for women
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Serum 25(OH)D levels above the median for men
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Dietary vitamin D intake
Number of subjects: 568
Study: 15088221

Group type: EXPERIMENTAL
Intervention: Social support treatments targeting appropriate use of the health care system
Number of subjects: 4310
Study: 12195181

Group type: EXPERIMENTAL
Intervention: Pelvic floor exercises and biofeedback treatment
Number of subjects: 83
Study: 10204584

Group type: EXPERIMENTAL
Intervention: Poststorage WBC-reduced platelets
Number of subjects: 30

Group type: COMPARATOR
Intervention: Plasma-depleted platelets
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Interleukin 6 levels
Number of subjects: 30
Study: 7753975

Group type: EXPERIMENTAL
Intervention: Nicotine gum
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 48
Study: 2406169

Group type: EXPERIMENTAL
Intervention: Home-visiting system with one or two weekly visits by domiciliary midwives
Number of subjects: 158

Group type: COMPARATOR
Intervention: Usual policy of the hospitals (control group)
Number of subjects: 158
Study: 396653

Group type: EXPERIMENTAL
Intervention: Pirenzepine (PRZ) 75 mg/day for 1 week followed by 50 mg/day for 3 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pirenzepine (PRZ) 100 mg/day for 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carbenoxolone (CB) 300 mg/day for 1 week followed by 200 mg/day for 3 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carbenoxolone (CB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pirenzepine (PRZ)
Number of subjects: 0
Study: 31480696

Group type: EXPERIMENTAL
Intervention: Unhealthy snacking frequency
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Day-to-day energy intake variability
Number of subjects: 73

Group type: COMPARATOR
Intervention: Shift-working nurses
Number of subjects: 73
Study: 28104402

Group type: EXPERIMENTAL
Intervention: Hispanic women with polycystic ovarian syndrome
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Non-Hispanic black women
Number of subjects: 702

Group type: COMPARATOR
Intervention: Non-Hispanic whites
Number of subjects: 702
Study: 29443478

Group type: EXPERIMENTAL
Intervention: Family Unification Program (FUP) with housing case management services
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Family Unification Program (FUP)
Number of subjects: 150
Study: 23053618

Group type: EXPERIMENTAL
Intervention: Immediate CAMP treatment (n = 15)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Waitlist (delayed treatment; n = 14)
Number of subjects: 29
Study: 20976468

Group type: EXPERIMENTAL
Intervention: Creatine supplementation for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Creatine supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20368858

Group type: EXPERIMENTAL
Intervention: Tissue glue
Number of subjects: 51

Group type: COMPARATOR
Intervention: Subcuticular suturing
Number of subjects: 51
Study: 17264451

Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 93
Study: 14550682

Group type: EXPERIMENTAL
Intervention: 1-Hz rTMS at 80% of right-hand muscle twitch threshold
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1-Hz rTMS at 90% of right-hand muscle twitch threshold
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1-Hz rTMS at 100% of right-hand muscle twitch threshold
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1-Hz rTMS at 110% of right-hand muscle twitch threshold
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1-Hz rTMS at 120% of right-hand muscle twitch threshold
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1-Hz rTMS at various intensities
Number of subjects: 10